News from Business Insider Markets
What is your interest today?
Tariffs
Investors
Ceo
Stock
Earnings
Shares
Stocks
Eqs
China
Nasdaq
Cet
Markets
Investment
Wall Street
Trade
Tesla
Revenue
Nvidia
Stock Market
Class Action
Securities
Economy
Bitcoin
Inflation
Us
Sales
Company
Trade War
Prices
Apple
Federal Reserve
Sp 500
Pvr
Crypto
Interest Rates
Guidance
Companies
Warren Buffett
Ipo
Amazon
Berkshire Hathaway
Shareholders
Federal Securities Laws
Walmart
Profit
Voting Rights
Investor
German Securities Trading Act
Trading
Elon Musk
Bond Yields
Taxes
Startups
Interactive
Us China Tariffs
Xp Inc
Flow
Sales Outlook
Rubean Ag
Retirement Investors
Business Insider Markets • Jun 03, 2025
Kamari Pharma Announces Closing of $23 Million Financing to Advance its First-In-Class Oral TRPV3 In...
Kamari Pharma secured $23 million in funding led by BRM Group and Pontifax to support the clinical development of its novel oral TRPV3 inhibitor targeting rare genetic skin conditi...
Read Full Article →